Suggested Readings

Rapid start antiretroviral therapies for improved engagement in HIV care: implementation science evaluation protocol.

Bourdeau B, Shade SB, Koester KA, et al. BMC Health Serv Res. 2023;23(1):503.

Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries.

Chinyere O, Nicolas Van de V, Bruce R, et al. Sex Transm Infect. 2021;97(1):18.

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, Sumitani J, Mehta CC, et al. Open Forum Infect Dis. 2018;5(6):ofy104.

A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a Federally Qualified Health Center in New Orleans.

Halperin J, Conner K, Butler I, et al. Open Forum Infect Dis. 2019;6(4):ofz161.

Toward ending the HIV epidemic: temporal trends and disparities in early ART initiation and early viral suppression among people newly entering HIV care in the United States, 2012–2018.

Li J, Humes E, Lee JS, et al. Open Forum Infect Dis. 2022;9(8):ofac336.

The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting.

Pilcher CD, Ospina-Norvell C, Dasgupta A, et al. J Acquir Immune Defic Syndr. 2017;74(1):44-51.

Long-acting injectable CAB/RPV is superior to oral ART in PWH with adherence challenges: ACTG A5359.

Rana AI, Bao Y, Zheng L, et al. Conference on Retroviruses and Opportunistic Infections (CROI); March 3-6, 2024; Denver, CO. Abstract 212.

Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.

Rodger AJ, Cambiano V, Bruun T, et al. JAMA. 2016;316(2):171-181.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, et al. Lancet. 2019;393(10189):2428-2438.

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.

Trickey A, Sabin CA, Burkholder G, et al. Lancet HIV. 2023;10(5):e295-e307.

Linked Resources


Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Branson BM, Handsfield HH, Lampe MA, et al. MMWR Recomm Rep. 2006;55(Rr-14):1-17.

Laboratory testing for the diagnosis of HIV infection: updated recommendations.

Centers for Disease Control and Prevention (CDC).

Preexposure prophylaxis for the prevention of HIV infection in the United States – 2021 update.


Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA Panel.

Gandhi RT, Bedimo R, Hoy JF, et al. JAMA. 2023;329(1):63-84.

Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.

US Department of Health and Human Services


Immediate ART initiation & restart: guide for clinicians.

AIDS Education and Training Center Program.

National Clinician Consultation Center.

University of California, San Francisco.


AIDSMap Resources

NAM Publications

Resources for persons living with HIV

Centers for Disease Control and Prevention

HIV resources

National Institutes of Health

Related activities
0.50 AMA PRA

Top 10 Questions About Managing a New HIV Diagnosis in Primary Care

Module 1

Faculty: Jason Halperin, MD, MPH, FIDSA
Release: 06/21/2024
Expiration: 06/21/2025